Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration
- PMID: 31653904
- PMCID: PMC6814705
- DOI: 10.1038/s41598-019-51769-7
Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration
Abstract
The purpose of this study was to assess which visual function measures are most strongly associated with vision-related quality of life (VRQoL) in age-related macular degeneration (AMD). A cross-sectional study of subjects with early AMD (n = 10), intermediate AMD (n = 42) and late AMD (n = 38) was conducted. Subjects were interviewed with the Impact of Vision Impairment (IVI) questionnaire. Functional tests performed included best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), visual acuity measured with the Moorfields Acuity Charts (MAC), contrast sensitivity, reading speed, mesopic and dark-adapted microperimetry. The relationship between VRQoL and visual function was assessed with multiple regressions controlling for confounders. Rasch analysis demonstrated the validity of the IVI to assess VRQoL through three subscales: reading and accessing information, mobility and independence, and emotional well-being. Subjects with late AMD had significant lower IVI scores on all subscales compared with intermediate and early AMD (p < 0.011). In the overall cohort, IVI subscales were associated with BCVA, LLVA, MAC-VA and contrast sensitivity (all p < 0.001). Among the subgroup of early and intermediate AMD subjects, reading and mobility subscales were significantly associated with MAC-VA (p < 0.013). These results suggest that MAC-VA is a useful, patient-relevant measure of visual impairment in AMD.
Conflict of interest statement
CenterVue SpA, Padua, Italy has provided research material (S-MAIA) for the conduct of this study. Center-Vue had no role in the design or conduct of the experiments. S. G. Pondorfer: Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); J. H. Terheyden: Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); M. Heinemann: Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F); M. W. M. Wintergerst: Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F), CenterVue (F), Heine Optotechnik (C, F), DigiSight Technologies (F), D-Eye (F) F.G. Holz: Heidelberg Engineering (F, C, R), Optos (F), Carl Zeiss MedicTec (F, C), CenterVue (F), Allergan (F, R), Alcon/Novartis (F, R), Genentech/Roche (F, R), Bayer (F, R), Acucela (F, R), Boehringer Ingelheim (F, R); R.P. Finger: Heidelberg Engineering (F), Optos (F), Carl Zeiss MedicTec (F),, CenterVue (F), Bayer (C), Novartis (C), Santen (C), Opthea (C), Novelion (C), Retina Implant (C), Oxford Innovation (C), Novartis (F).
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
